Globus Medical, Inc. (GMED)
82.92
+1.66
(+2.04%)
USD |
NYSE |
Oct 29, 16:00
84.00
+1.08
(+1.31%)
After-Hours: 20:00
Globus Medical Enterprise Value : 10.43B for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 10.43B |
| October 27, 2026 | 10.38B |
| October 26, 2026 | 10.50B |
| October 23, 2026 | 10.45B |
| October 22, 2026 | 10.48B |
| October 21, 2026 | 10.08B |
| October 20, 2026 | 10.12B |
| October 19, 2026 | 9.673B |
| October 16, 2026 | 9.815B |
| October 15, 2026 | 10.10B |
| October 14, 2026 | 9.762B |
| October 13, 2026 | 9.763B |
| October 12, 2026 | 9.752B |
| October 09, 2026 | 9.539B |
| October 08, 2026 | 9.361B |
| October 07, 2026 | 9.418B |
| October 06, 2026 | 9.778B |
| October 05, 2026 | 9.796B |
| October 02, 2026 | 9.666B |
| October 01, 2026 | 9.506B |
| September 30, 2026 | 9.572B |
| September 29, 2026 | 9.678B |
| September 28, 2026 | 9.556B |
| September 25, 2026 | 9.521B |
| September 24, 2026 | 9.488B |
| Date | Value |
|---|---|
| September 23, 2026 | 9.446B |
| September 22, 2026 | 9.611B |
| September 21, 2026 | 9.490B |
| September 18, 2026 | 9.462B |
| September 17, 2026 | 9.473B |
| September 16, 2026 | 9.621B |
| September 15, 2026 | 9.544B |
| September 14, 2026 | 9.689B |
| September 11, 2026 | 9.477B |
| September 10, 2026 | 9.392B |
| September 09, 2026 | 9.521B |
| September 08, 2026 | 9.591B |
| September 04, 2026 | 10.03B |
| September 03, 2026 | 10.00B |
| September 02, 2026 | 10.35B |
| September 01, 2026 | 10.32B |
| August 31, 2026 | 10.44B |
| August 28, 2026 | 10.66B |
| August 27, 2026 | 10.60B |
| August 26, 2026 | 10.67B |
| August 25, 2026 | 10.65B |
| August 24, 2026 | 10.80B |
| August 21, 2026 | 11.18B |
| August 20, 2026 | 11.02B |
| August 19, 2026 | 11.38B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 205.26B |
| Merit Medical Systems, Inc. | 5.875B |
| Teleflex, Inc. | 8.447B |
| The Cooper Cos., Inc. | 13.68B |
| Intuitive Surgical, Inc. | 150.01B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 151.57M |
| Revenue (Quarterly) | 789.61M |
| Total Expenses (Quarterly) | 638.04M |
| EPS Diluted (Quarterly) | 1.103 |
| Gross Profit Margin (Quarterly) | 65.92% |
| Profit Margin (Quarterly) | 19.20% |
| Earnings Yield | 4.72% |
| Operating Earnings Yield | 5.97% |
| Normalized Earnings Yield | 4.933 |